Joseph Bamberger
LinkedIn Copy
Joseph — congrats on launching Geneva Private Equity. been working on outbound origination with medtech and diagnostics investors and your fund has been on my radar. would be good to connect.
Joseph — though we both spent time in PE (you building Geneva, me at Treis in London), I've seen first-hand how challenging early proprietary origination can be. Been helping funds like Mentmore and Axiom with their outbound origination — curious what email infrastructure you're using these days — still mostly on shared IPs like Instantly, or have you moved to private/dedicated senders? Happy to share what's working best for similar medtech and diagnostics funds if useful. — Russ
Email Copy
Joseph — hope you're having a good Wednesday. wanted to reach out — congrats on launching Geneva PE, always impressed by those who've taken the leap. though we share a PE background, I hope to one day do the same. in the meantime I've been working on outbound origination with funds like Axiom Equity and Wingman Growth Partners — curious what email infrastructure you're using for your origination outreach these days — still mostly on shared IPs like Instantly, or have you moved to private/dedicated senders? very best, Russell linkedin.com/in/russellt23
Prospect Research
## PROSPECT INFORMATION: Name: Joseph Bamberger Title: Founder and CEO Fund: Geneva Private Equity Background: Please provide the Profile Data and Posts Data you would like me to summarize. Once you paste the data, I will extract the current focus, background, skills, and specific quotes with dates from their posts as requested. Fund details: - Description: Geneva Private Equity invests in post-clinical MedTech companies positioned for scalable growth. We focus on technologies with completed clinical validation and clear pathways to commercialization, including diagnostics, medical devices, digital therapeutics, and advanced healthcare platforms. Our approach blends growth equity with deep operational support. Geneva accelerates time-to-market through regulatory expertise, clinical strategy, and established distribution and health system networks. Our team brings decades of leadership experience from organizations including Abbott, Roche, Boehringer Ingelheim, Quest Diagnostics, Johns Hopkins, and major U.S. health systems. We partner closely with founders to transform validated technologies into market-leading healthcare solutions. Geneva is committed to advancing breakthrough innovations that shape the future of global health. - Website: https://www.geneva-pe.com/ - Location: New York, New York, United States - Lead qualification: Research: - Query: =Geneva Private Equity Joseph Bamberger recent investments fund thesis - Answer: Geneva Private Equity recently funded NXXIM, an AI-powered medical imaging platform. Joseph Bamberger leads the firm, focusing on scaling post-clinical medtech companies. Geneva PE specializes in diagnostics and data analytics to improve clinical outcomes.